Management and Outcomes of Facial Nerve Hemangiomas: A Systematic Review of the Literature
Journal of Neurological Surgery Part B: Skull Base · 01.02.2024 · 85 (S 01 S 01) · S1-S398
DOI: 10.1055/s-0044-1779989 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.02.2024. Verfasst von Emal Lesha und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Facial nerve hemangiomas are a rare entity of skull base lesions that arise within the temporal bone and affect cranial nerve VII. They are vascular malformations arising from the vascular plexuses surrounding the nerve, are slow growing and overall benign in nature, but can cause significant CN VII dysfunction. Facial nerve hemangiomas can arise within different segments of CN VII within the temporal bone. In this study, we perform a systematic review of reported facial nerve hemangiomas in the literature, and provide an overview on management options and reported outcomes.
Objective
To study and understand management options of facial nerve hemangiomas, surgical approaches, and facial nerve outcomes after surgery.
Method
A systematic review was conducted following the PRISMA guidelines. PubMed, EMBASE, Scopus, and Cochrane were searched from database inception to November 7, 2022.
Results
Our search yielded a total of 1,682 articles, which after critical assessment led to 40 articles being included in final review. Overall, a total 176 patients with facial hemangioma were included in the study, with mean age of 42.8 years. 57% of patients were male, 80% of them had facial nerve palsy at presentation with mean symptom duration of 2.59 years. 34% of patients also presented with some degree of hearing loss. 71% of the hemangiomas were located in the geniculate ganglion, and 22% in the internal auditory canal. Resection of the hemangioma was pursued in 96% of patients, 52% of which required a facial nerve sacrifice. Preoperatively, 65% of the patients had facial nerve weakness of House-Brackmann IV–VI, but only 35% postoperatively. Duration of facial nerve palsy at presentation did not make a significant difference in postoperative facial nerve palsy improvement ( p = 0.98). Patients were followed for a mean of 3.04 years postoperatively. Lesion recurrence was reported in only 1.4% of resected cases at last follow-up.
Conclusion
Facial nerve hemangiomas are a rare entity of skull base temporal bone lesions that affect cranial nerve VII. Surgical resection is the treatment of choice, and it does lead to improvement of facial nerve palsy in the majority of patients ([ Figs. 1 ], [ 2 ]; [ Tables 1 ], [ 2 ]). Table 1 Table 2 Fig. 1 Fig. 2 Publication History Article published online: 05 February 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Lesha, E., Parikh, K., Dugan, J., Kraemer, A., Cecia, A., Orr, T., & Khan, N. (2024). Management and Outcomes of Facial Nerve Hemangiomas: A Systematic Review of the Literature. Journal of Neurological Surgery Part B: Skull Base, 85(S 01 S 01), S1-S398. https://doi.org/10.1055/s-0044-1779989
Vancouver
Lesha E, Parikh K, Dugan J, Kraemer A, Cecia A, Orr T, et al. Management and Outcomes of Facial Nerve Hemangiomas: A Systematic Review of the Literature. Journal of Neurological Surgery Part B: Skull Base. 2024;85(S 01 S 01):S1-S398. doi:10.1055/s-0044-1779989
BibTeX
@article{Lesha2024,
author = {Lesha, Emal and Parikh, Kara and Dugan, John and Kraemer, Alexandra and Cecia, Arba and Orr, Taylor and Khan, Nickalus},
title = {Management and Outcomes of Facial Nerve Hemangiomas: A Systematic Review of the Literature},
journal = {Journal of Neurological Surgery Part B: Skull Base},
year = {2024},
volume = {85},
number = {S 01 S 01},
pages = {S1--S398},
doi = {10.1055/s-0044-1779989}
}
EUVIMED